BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1 AND Treatment
118 results:

  • 1. MUC1 promotes glioblastoma progression and TMZ resistance by stabilizing EGFRvIII.
    Tong F; Zhao JX; Fang ZY; Cui XT; Su DY; Liu X; Zhou JH; Wang GX; Qiu ZJ; Liu SZ; Fu JQ; Kang CS; Wang JC; Wang QX
    Pharmacol Res; 2023 Jan; 187():106606. PubMed ID: 36516884
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Gastric SWI/SNF complex deletion-associated undifferentiated carcinoma with rhabdoid phenotype: a clinicopathological and molecular analysis].
    Jin YP; Wang L; Wang Y; Wu DY; Zhang H; Xia QX
    Zhonghua Bing Li Xue Za Zhi; 2022 Dec; 51(12):1229-1234. PubMed ID: 36480831
    [No Abstract]    [Full Text] [Related]  

  • 3. Survival times of patients with glioblastoma in low- and middle-income countries: a systematic review and meta-analysis.
    Dy LF; Ong EP; Espiritu AI; Spears J; Omar AT
    Neurosurg Rev; 2022 Oct; 45(5):3393-3403. PubMed ID: 36044130
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies.
    Ruggeri RM; Benevento E; De Cicco F; Fazzalari B; Guadagno E; Hasballa I; Tarsitano MG; Isidori AM; Colao A; Faggiano A;
    J Endocrinol Invest; 2023 Feb; 46(2):213-234. PubMed ID: 36038743
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries.
    Global Retinoblastoma Study Group
    Lancet Glob Health; 2022 Aug; 10(8):e1128-e1140. PubMed ID: 35839812
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patients.
    El Sharouni MA; Scolyer RA; van Gils CH; Ch'ng S; Nieweg OE; Pennington TE; Saw RP; Shannon K; Spillane A; Stretch J; Witkamp AJ; Sigurdsson V; Thompson JF; van Diest PJ; Lo SN
    Eur J Cancer; 2022 May; 167():133-141. PubMed ID: 35216870
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Apigenin inhibits growth of melanoma by suppressing miR-512-3p and promoting the G1 phase of cell cycle involving the p27 kip1 protein.
    Xie Q; Zhang R; Liu D; Yang J; Hu Q; Shan C; Li X
    Mol Cell Biochem; 2022 May; 477(5):1569-1582. PubMed ID: 35194732
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cyclophosphamide inhibits Pax5 methylation to regulate the growth of retinoblastoma via the Notch1 pathway.
    Jin L; Ma X; Lei X; Tong J; Wang R
    Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S497-S508. PubMed ID: 34658283
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Nuclear receptor NR5A2 negatively regulates cell proliferation and tumor growth in nervous system malignancies.
    Gkikas D; Stellas D; Polissidis A; Manolakou T; Kokotou MG; Kokotos G; Politis PK
    Proc Natl Acad Sci U S A; 2021 Sep; 118(39):. PubMed ID: 34561301
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets.
    van Riet J; van de Werken HJG; Cuppen E; Eskens FALM; Tesselaar M; van Veenendaal LM; Klümpen HJ; Dercksen MW; Valk GD; Lolkema MP; Sleijfer S; Mostert B
    Nat Commun; 2021 Jul; 12(1):4612. PubMed ID: 34326338
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Active notch protects MAPK activated melanoma cell lines from MEK inhibitor cobimetinib.
    Porcelli L; Mazzotta A; Garofoli M; Di Fonte R; Guida G; Guida M; Tommasi S; Azzariti A
    Biomed Pharmacother; 2021 Jan; 133():111006. PubMed ID: 33202284
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. AKT/GSK-3β/β-catenin signaling pathway participates in erythropoietin-promoted glioma proliferation.
    Tang Z; Yang G; Wang X; Chen F; Liao Z; Zhang Z; Liu Z; Zeng W; Fang M; Wang W; Sun X; Huo G
    J Neurooncol; 2020 Sep; 149(2):231-242. PubMed ID: 32909117
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Retinoblastoma co-repressor 1 (RB) and cyclin-dependent kinase inhibitor (CDKN) as a multi-gene panel for differentiating pulmonary from non-pulmonary origin in metastatic neuroendocrine carcinomas.
    Krishnamurthy K; Cusnir M; Schwartz M; Sriganeshan V; Poppiti RJ
    Pathol Res Pract; 2020 Sep; 216(9):153051. PubMed ID: 32825935
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Pristimerin-induced uveal melanoma cell death via inhibiting PI3K/Akt/FoxO3a signalling pathway.
    Yan F; Liao R; Silva M; Li S; Jiang Y; Peng T; Lazarovici P; Zheng W
    J Cell Mol Med; 2020 Jun; 24(11):6208-6219. PubMed ID: 32347651
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Radiation exposure in nurses during care of
    Taniguchi Y; Wakabayashi H; Inaki A; Kayano D; Yamada M; Kinuya S
    Ann Nucl Med; 2020 Jun; 34(6):441-447. PubMed ID: 32297135
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel Pathogenic Variant and Review of Published Cases.
    Frederiksen A; Rossing M; Hermann P; Ejersted C; Thakker RV; Frost M
    J Clin Endocrinol Metab; 2019 Sep; 104(9):3637-3646. PubMed ID: 30990521
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patients.
    Yu L; Xu J; Liu J; Zhang H; Sun C; Wang Q; Shi C; Zhou X; Hua D; Luo W; Bian X; Yu S
    Neuro Oncol; 2019 Jun; 21(6):742-754. PubMed ID: 30753603
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Reduced Expression of PROX1 Transitions Glioblastoma cells into a Mesenchymal Gene Expression Subtype.
    Goudarzi KM; Espinoza JA; Guo M; Bartek J; Nistér M; Lindström MS; Hägerstrand D
    Cancer Res; 2018 Oct; 78(20):5901-5916. PubMed ID: 30135192
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Inactivation of Citron Kinase Inhibits Medulloblastoma Progression by Inducing Apoptosis and cell Senescence.
    Pallavicini G; Sgrò F; Garello F; Falcone M; Bitonto V; Berto GE; Bianchi FT; Gai M; Chiotto AMA; Filippi M; Cutrin JC; Ala U; Terreno E; Turco E; Cunto FD
    Cancer Res; 2018 Aug; 78(16):4599-4612. PubMed ID: 29921697
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genetics of medullary thyroid cancer: An overview.
    Accardo G; Conzo G; Esposito D; Gambardella C; Mazzella M; Castaldo F; Di Donna C; Polistena A; Avenia N; Colantuoni V; Giugliano D; Pasquali D
    Int J Surg; 2017 May; 41 Suppl 1():S2-S6. PubMed ID: 28506408
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.